malignant pleural mesothelioma

Showing 1 - 25 of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)

Recruiting
  • Malignant Pleural Mesothelioma
  • E-Nose testing
  • Research blood
  • Basking Ridge, New Jersey
  • +6 more
Sep 8, 2023

Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • CTX131
  • Nashville, Tennessee
    Research Site 1
Mar 21, 2023

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Malignant Pleural Mesothelioma Trial (Proton beam therapy)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Proton beam therapy
  • (no location specified)
Dec 14, 2022

Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

Recruiting
  • Malignant Pleural Effusion
  • +3 more
  • Leicester, United Kingdom
  • +5 more
Oct 28, 2022

Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • +7 more
  • Regorafenib in combination with Tislelizumab
  • (no location specified)
Oct 12, 2022

Malignant Pleural Mesothelioma Trial in Worldwide (MORAb-009 (Amatuximab), Pemetrexed, Cisplatin)

Completed
  • Malignant Pleural Mesothelioma
  • MORAb-009 (Amatuximab)
  • +2 more
  • Birmingham, Alabama
  • +27 more
Aug 24, 2022

Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

Recruiting
  • Malignant Pleural Mesothelioma
  • Chemotherapy Effect
  • hyperthermic intrathoracic chemotherapy
  • Cairo, Egypt
    Ain Shams University hospitals
Aug 18, 2022

Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer Trial in China (APG-2449)

Recruiting
  • Advanced Solid Cancer
  • +4 more
  • Beijing, Beijing, China
  • +9 more
Aug 17, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Malignant Pleural Mesothelioma Trial in United States (Pembrolizumab, IMPRINT)

Recruiting
  • Malignant Pleural Mesothelioma
  • Basking Ridge, New Jersey
  • +6 more
Jul 13, 2022

Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 16, 2022

Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

Recruiting
  • Malignant Pleural Mesothelioma
  • Safety
  • Expansion Cohort
  • New York, New York
    Icahn School of Medicine Mount Sinai
Mar 31, 2022

Previously Unresectable Malignant Pleural Mesothelioma Treated

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Unresectable Malignant Neoplasm
  • Data collection
  • Brest, France
  • +4 more
Mar 30, 2022

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

Safety of Malignant Pleural Mesothelioma, Treated by

Completed
  • Malignant Pleural Mesothelioma
  • Data collection
  • Bayonne, France
  • +4 more
Feb 3, 2022

Malignant Pleural Mesothelioma Trial in United States (Nivolumab, Pemetrexed, Cisplatin or Carboplatin)

Recruiting
  • Malignant Pleural Mesothelioma
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2022

Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • rAd-IFN
  • +2 more
  • Los Angeles, California
  • +41 more
Oct 25, 2021

Malignant Pleural Mesothelioma Trial in Toronto (Pre-op RT +/- chemo)

Recruiting
  • Malignant Pleural Mesothelioma
  • Pre-op RT +/- chemotherapy
  • Toronto, Ontario, Canada
    University Health Network
Oct 4, 2021

Malignant Pleural Mesothelioma Trial in Zurich (intracavitary cisplatin-fibrin)

Completed
  • Malignant Pleural Mesothelioma
  • intracavitary cisplatin-fibrin
  • Zurich, ZH, Switzerland
    University Hospital Zurich, Division of Thoracic Surgery
Sep 28, 2021

Malignant Pleural Mesothelioma, Solid Tumors Trial in United States (pemetrexed, cisplatin and CBP501, pemetrexed and cisplatin,

Completed
  • Malignant Pleural Mesothelioma
  • Solid Tumors
  • pemetrexed, cisplatin and CBP501
  • +2 more
  • Scottsdale, Arizona
  • +11 more
Jun 30, 2021

Malignant Pleural Mesothelioma Trial in Boston (VS-6063)

Terminated
  • Malignant Pleural Mesothelioma
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 13, 2021